期刊文献+

人源抗狂犬病病毒scFv噬菌体抗体库的构建及筛选 被引量:4

Construction and screening of human anti-rabies virus scFv phage antibody library
原文传递
导出
摘要 目的构建人源抗狂犬病病毒单链抗体(Single-chain fragment variable,scFv)噬菌体抗体库,并进行筛选。方法以接种过狂犬病疫苗的21份高效价的健康人外周血为原料,提取淋巴细胞总RNA,PCR扩增VH、Vκ、Vλ基因,重叠延伸PCR扩增获得scFv基因,克隆入噬菌粒pS100,电转化E.coli TG1,建立scFv初级抗体库,并进行基因序列分析及鉴定。以灭活的狂犬病病毒为抗原,进行3轮scFv噬菌体抗体库的富集筛选,随机挑取单克隆,制备噬菌体抗体颗粒,并进行ELISA分析,阳性克隆进行序列分析,采用快速荧光灶抑制试验(Rapid fluorescent facus inhibition test,RFFIT)检测噬菌体抗体颗粒的中和活性。结果获得了库容为1.7×108的人源抗狂犬病病毒scFv噬菌体抗体库,该抗体库具有较好的序列正确率和多样性,经3轮筛选后,ELISA分析显示,共获得24个序列各不相同的针对狂犬病病毒的阳性克隆,对其中7个克隆的噬菌体抗体颗粒进行RFFIT检测,均具有中和活性。结论已成功构建了人源抗狂犬病病毒scFv噬菌体抗体库,并建立了筛选方法。 Objective To construct a human anti-rabies virus scFv phage antibody library and develop a method for screening.Methods Total RNAs of lymphocytes were extracted from 21 high titer peripheral blood samples of healthy donors immunized with rabies vaccine,with which VH、Vκ and Vλ genes were amplified by PCR and scFv gene by overlap and extension PCR and cloned into phagemid pS100.Primary antibody library were established by transformation of E.coli TG1 with the recombinant phagemid by electroporation,then sequenced and identified.Three rounds of enrichment and screening were performed using inactivated rabies virus as antigen.Single clones were randomly selected,prepared into phage antibody particles and analyzed by ELISA.The positive clones were sequenced and determined for neutralizing activity of phage antibody particles by rapid fluorescent focus inhibition test(RFFIT).Results A human anti-rabies virus scFv phage display library with a capacity of 1.7 × 108 individual clones were successfully constructed,which showed high correct rate of sequence and high diversity.After three rounds of screening,ELISA showed that 24 positive clones with different sequences were obtained,of which 7 were determined by RFFIT and showed neutralizing activity.Conclusion A human anti-rabies virus scFv phage antibody library was successfully constructed,and a method for screening was developed.
出处 《中国生物制品学杂志》 CAS CSCD 2012年第12期1578-1582,共5页 Chinese Journal of Biologicals
关键词 狂犬病病毒 单链抗体 噬菌体展示技术 抗体库 Rabies virus scFv Phage display technique Antibody library
  • 相关文献

参考文献6

二级参考文献49

  • 1董关木.狂犬病的防治、疫苗和抗血清的安全性探讨[J].中国预防医学杂志,2006,7(4):362-365. 被引量:35
  • 2李怀昕,汪武新,谢远辉,杨卫红,彭晋先,孙蔓,耿艺介,高世同,黄达娜,张仁利.830例狂犬疫苗接种后抗体检测结果分析[J].中国热带医学,2006,6(12):2153-2154. 被引量:3
  • 3World Health Organization. WHO expert consultation on rabies, 2004, First Report; WHO technical report series # 931. World Health Organization[ M]. Geneva, Switzerland, 2005.
  • 4Shanbag P, Shah N, Kulkarni M, et al. Protecting Indian schoolchildren against rabies: pre -exposure vaccinalion with purified chick embryo cell vaccine (PCECV) or purified verocell rabies vaccine (PVRV) [J]. Hum Vaccine, 2008, 4(5):365 -369.
  • 5Manickama R, Basheer MD, Jayakumar R, et al. Post exposure prophylaxis (PEP) of rabies - infected Indian street dogs [ J ] . Vaccine, 2008, 26(51 ) : 6564 -6568.
  • 6Shiota S, Mannen K, Matsumoto T, et al. Development and evaluation of a rapid neutralizing antibody test for rabies [ J ]. J Virol Methods, 2009, [ Epub ahead of print].
  • 7Welch RJ, Anderson BL, Litwin CM. An evaluation of two commercially available ELISAs and one in -house reference laboratory ELISA for the determination of human anti - rabies virus antlbodies [ J ]. J Med Microbiol, 2009, 58 ( Pt 6) : 806 - 810.
  • 8Servat A, Wasniewski M, Cliquet F. Tools for rabies serology to monitor the effectiveness of rabies vaccination in domestic and wild carnivores[ J ]. Dev Biol (Basel) ,2006, 125 : 91 - 94.
  • 9Peharpre D, Cliquet F, Sagne E, et al. Comparison of visual microscopic and computer - automated fluorescence detection of rabies virus neutralizing antibodies[J]. J Vet Diagn Invest,1999, 11(4) : 330 -333.
  • 10Kbawplod P, Inoue K, Shoji Y, et al. A novel rapid fluorescent focus inhibition test for rabies virus using a recombinant rabies virus visualizing a green fluorescent protein [ J ].J Virol Methods, 2005, 125 (1) : 35 -40.

共引文献44

同被引文献24

  • 1乔媛媛,王琰,陈晓穗,王欲晓,化冰.大容量噬菌体抗体库的构建及鉴定[J].中华微生物学和免疫学杂志,2004,24(3):194-197. 被引量:27
  • 2Langle-Rouault F, Patzel V, Benavente A, et al. Up to 100-fold increase of apparent gene expression in the presence of Epstein-Barrvirus oriP sequences and EBNAI: implications of the nuclear import of plasmids[J]. Journal of Virology, 1998, 72(7): 6181-6185.
  • 3Inoue N, Harada S, Honma T, et al. The domain of Epstein-Barr virus nuclear antigen 1 essential for binding to oriP region has a sequence fitted for the hypothetical basic-helix-loop-helix structure [J]. Virology, 1991, 182(1): 84-93.
  • 4Hacker DL, Kiseljak D, Rajendra Y, et al. Polyethyleneimine-based transiem gene expression processes for suspension-adapted HEK-293E and CHO-DG44 cells [J]. Protein Expression and Purification, 2013, 92(1): 67-76.
  • 5Rajendra Y, Kiseljak D, Baldi L, et al. Influence of glutamine on transient and stable recombinant protein production in CHO and HEK-293 cells[J]. BMC Proceedings, 2011, 5(8): 1-3.
  • 6Tom R, Bisson L, Durocher Y. Transfection of HEK293-EBNA1 Cells in Suspension with Linear PEI for Production of Recombinant Proteins[J]. Cold Spring Harbor Protocols, 2008, 3(3): 1-4.
  • 7Sun X, Hia HC, Goh PE, et al. High-density transient gene expression in suspension-adapted 293 EBNA1 cells [J]. Biotecfinology and Bioengineering, 2008, 99(1): 108-116.
  • 8You M, Liu Y, Chen Y, et al. Maximizing antibody production in suspension-cultured mammalian cells by the customized transient gene expression method [J]. Bioseience Biotechnology Biochemistry, 2013, 77(6): 1207-1213.
  • 9Wulhfard S, Baldi L, Hacker DL, et al. Valproic acid enhances recombinant mRNA and protein levels in transiently transfected Chinese hamster ovary cells [J]. Journal of Biotechnology, 2010, 148 (2-3): 128-132.
  • 10Rajendra Y, Kiseljak D, Baldi L, et al. Reduced glutamine concentration improves protein production in growth-arrested CHO-DG44 and HEK-293E cells[J]. Biotechnol Letters, 2012, 34(4): 619-626.

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部